CHLORATES
HAZARDTEXT ®
Information to help in the initial response for evaluating chemical incidents
-IDENTIFICATION
SYNONYMS
B-herbtox Chlorate of soda Chloric acid, sodium salt Desolat Natriumchlorat Natrium chloraat (Dutch) Natrium chlorat (German) Sodium chlorate, aqueous solution CAS 7775-09-9 Chlorate of potash Potash chlorate Potassium oxymuriate Potcrate Berthollet salt Chloric acid, potassium salt Kaliumchlorat Pearl ash (potassium chlorate) CAS 3811-04-9 Chloric acid, barium salt CAS 13477-00-4 CHLORATES, INORGANIC, AQUEOUS SOLUTION, N.O.S. CHLORATE AND MAGNESIUM CHLORIDE MIXTURE CHLORATE AND BORATE MIXTURE
B-herbtox Chlorate of soda Chloric acid, sodium salt Desolat Natriumchlorat Natrium chloraat (Dutch) Natrium chlorat (German) Sodium chlorate, aqueous solution CAS 7775-09-9
CHLORATES, INORGANIC, AQUEOUS SOLUTION, N.O.S. CHLORATE AND MAGNESIUM CHLORIDE MIXTURE CHLORATE AND BORATE MIXTURE
IDENTIFIERS
3210-Chlorates, inorganic, aqueous solution, n.o.s. 1461-Chlorates, inorganic, n.o.s.
4918721 (CHLORATE, N.O.S.) 4918610 (CHLORATE, N.O.S., WET)
SYNONYM REFERENCE
USES/FORMS/SOURCES
Chlorates are a combination of a metal or hydrogen and the chlorate monovalent radical. Chlorates are strong oxidizers used in the manufacture of dyes, explosives, matches, printing fabrics, weed killers, and as a weak antiseptic. 2 to 3% solutions have been used as a mouthwash (Budavari, 1996). POTASSIUM PERCHLORATE is used in the treatment of hyperthyroidism. SODIUM AND POTASSIUM CHLORATE were former frequent ingredients in mouthwashes, gargles, toothpaste, and medicinal lotions. Chlorate salts are currently obsolete as local antiseptics (Budavari, 1996). BARIUM CHLORATE is a common oxidizer in explosives and fireworks (Budavari, 1996). A few fatalities have been described due to taking sodium chlorate in error for table salt or epsom salts which the salt resembles physically. Chlorates are also used as herbicides (Smith & Oehme, 1991).
Chlorate, n.o.s. is a crystalline compound. Chlorate, n.o.s., wet, is a slurry or sludge of white crystalline compounds (AAR, 1987).
-CLINICAL EFFECTS
GENERAL CLINICAL EFFECTS
Chlorates are principally toxic by ingestion and inhalation. They are very potent oxidizing agents; exposure may result in hemolysis with methemoglobin formation and secondary DIC. Chlorates are nephrotoxic; acute renal failure may occur. Chlorate poisoning is characterized by a latent period of a few hours, followed initially with nausea, vomiting and diarrhea, followed by arterial hypotension, cyanosis, hemolysis and subsequent renal failure.
- POTENTIAL HEALTH HAZARDS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004)
Inhalation, ingestion or contact (skin, eyes) with vapors or substance may cause severe injury, burns or death. Fire may produce irritating, corrosive and/or toxic gases. Runoff from fire control or dilution water may cause pollution.
-FIRST AID
FIRST AID AND PREHOSPITAL TREATMENT
Although activated charcoal is reported not to adsorb chlorate in vitro (Steffen & Wetzel, 1985), its use is recommended until definitive quantitative data are available. PREHOSPITAL ACTIVATED CHARCOAL ADMINISTRATION Consider prehospital administration of activated charcoal as an aqueous slurry in patients with a potentially toxic ingestion who are awake and able to protect their airway. Activated charcoal is most effective when administered within one hour of ingestion. Administration in the prehospital setting has the potential to significantly decrease the time from toxin ingestion to activated charcoal administration, although it has not been shown to affect outcome (Alaspaa et al, 2005; Thakore & Murphy, 2002; Spiller & Rogers, 2002). In patients who are at risk for the abrupt onset of seizures or mental status depression, activated charcoal should not be administered in the prehospital setting, due to the risk of aspiration in the event of spontaneous emesis. The addition of flavoring agents (cola drinks, chocolate milk, cherry syrup) to activated charcoal improves the palatability for children and may facilitate successful administration (Guenther Skokan et al, 2001; Dagnone et al, 2002).
CHARCOAL DOSE Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005). Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
ADVERSE EFFECTS/CONTRAINDICATIONS Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information. Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
-MEDICAL TREATMENT
LIFE SUPPORT
- Support respiratory and cardiovascular function.
SUMMARY
- FIRST AID - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004)
Move victim to fresh air. Call 911 or emergency medical service. Give artificial respiration if victim is not breathing. Administer oxygen if breathing is difficult. Remove and isolate contaminated clothing and shoes. Contaminated clothing may be a fire risk when dry. In case of contact with substance, immediately flush skin or eyes with running water for at least 20 minutes. Keep victim warm and quiet. Ensure that medical personnel are aware of the material(s) involved and take precautions to protect themselves.
INHALATION EXPOSURE INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
DERMAL EXPOSURE EYE EXPOSURE EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
ORAL EXPOSURE Significant esophageal or gastrointestinal tract irritation or burns may occur following ingestion. The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation. GASTRIC LAVAGE: Consider after ingestion of a potentially life-threatening amount of poison if it can be performed soon after ingestion (generally within 1 hour). Protect airway by placement in the head down left lateral decubitus position or by endotracheal intubation. Control any seizures first. ACTIVATED CHARCOAL: Administer charcoal as a slurry (240 mL water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents, 25 to 50 g in children (1 to 12 years), and 1 g/kg in infants less than 1 year old. SODIUM THIOSULFATE - Consider administering sodium thiosulfate to symptomatic patients to inactivate the chlorate ion. Administer 2 to 5 g orally or IV in 200 ml of 5% sodium bicarbonate. ALKALINE DIURESIS - Assure adequate hydration and renal function. Administer 88 to 132 mEq/L sodium bicarbonate and 20 to 40 mEq KCl (as needed) in D5W or other fluid to produce adequate urine flow and urine pH of at least 7.5. Additional doses may be needed to maintain an alkaline urine. Monitor fluid balance and serum potassium. Obtain hourly intake/output and hourly urine pH. METHEMOGLOBINEMIA: Determine the methemoglobin concentration and evaluate the patient for clinical effects of methemoglobinemia (ie, dyspnea, headache, fatigue, CNS depression, tachycardia, metabolic acidosis). Treat patients with symptomatic methemoglobinemia with methylene blue (this usually occurs at methemoglobin concentrations above 20% to 30%, but may occur at lower methemoglobin concentrations in patients with anemia, or underlying pulmonary or cardiovascular disorders). Administer oxygen while preparing for methylene blue therapy. METHYLENE BLUE: INITIAL DOSE/ADULT OR CHILD: 1 mg/kg IV over 5 to 30 minutes; a repeat dose of up to 1 mg/kg may be given 1 hour after the first dose if methemoglobin levels remain greater than 30% or if signs and symptoms persist. NOTE: Methylene blue is available as follows: 50 mg/10 mL (5 mg/mL or 0.5% solution) single-dose ampules and 10 mg/1 mL (1% solution) vials. Additional doses may sometimes be required. Improvement is usually noted shortly after administration if diagnosis is correct. Consider other diagnoses or treatment options if no improvement has been observed after several doses. If intravenous access cannot be established, methylene blue may also be given by intraosseous infusion. Methylene blue should not be given by subcutaneous or intrathecal injection. NEONATES: DOSE: 0.3 to 1 mg/kg. Concomitant use of methylene blue with serotonergic drugs, including serotonin reuptake inhibitors (SRIs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), norepinephrine-dopamine reuptake inhibitors (NDRIs), triptans, and ergot alkaloids may increase the risk of potentially fatal serotonin syndrome. EXCHANGE TRANSFUSION - Exchange transfusion combined with hemodialysis or peritoneal dialysis should be considered in severely intoxicated patients. MONITOR RENAL FUNCTION - Renal function should be monitored carefully especially following ingestion of 20 to 30 grams or more in which renal insufficiency occurs in 80% of these cases. Monitor fluids and electrolytes in symptomatic patients.
-RANGE OF TOXICITY
MINIMUM LETHAL EXPOSURE
Amounts ingested ranged from 15 to 300 grams of sodium chlorate in 7 fatal adult cases (Helliwell & Nunn, 1979), however, doses of up to 150 to 200 grams have been survived (Steffen & Seitz, 1981; O'Grady & Jarecsni, 1971). Ingestion of 90 grams of sodium chlorate was fatal in a 78-year-old man (O'Grady & Jarecsni, 1971). Ingestion of 7.5 grams of potassium chlorate in a toothpaste formulation was fatal in an adult (Bernstein, 1930). Ingestion of 10 grams/day of potassium chlorate for 3 days resulted in death in a 43-year-old man (total dose 30 to 35 grams) (Cochrane & Smith, 1940). An acute or cumulative dose of 7.5 to 35 grams has been lethal in adults; however, doses of 150 grams or greater have been survived.
MAXIMUM TOLERATED EXPOSURE
INHALATION The smallest recorded dose was inhaled by a gardener after using a concentrated solution in an atomizer; he developed renal failure but subsequently recovered (Jackson et al, 1961). Chlorates are principally toxic by ingestion and inhalation with no known reports of skin absorption.
INGESTION Less than 20 wooden (330 milligrams) or 2 books of paper matches (220 milligrams) do not contain enough potassium chlorate to be harmful to a child. Acute ingestion of 150 to 200 grams of sodium chlorate resulted in serious toxicity and survival in adults (Steffen & Seitz, 1981). In 5 adults who recovered from sodium chlorate poisoning, the amount ingested was 1-2, 5, 30, 45, and 100 grams (Helliwell & Nunn, 1979). A 28-year-old male recovered over 32 days after ingesting 40 grams of sodium chlorate. He developed extensive hemolysis, progressive kidney failure, liver dysfunction and hyperkalemia (Klendshoj et al, 1962). Acute ingestion of 20 grams of sodium chlorate by a 15-year-old boy resulted in cyanosis, anuria, and DIC (Lee et al, 1970). Severe toxicity (renal failure, jaundice, methemoglobinemia) was described in a 13-year-old boy who dipped his finger into sodium chlorate crystals and licked the finger (Stavrou et al, 1978). A 42-year-old man developed hypotension, methemoglobinemia, acute renal failure, hemolytic anemia, and DIC after ingesting approximately 50 mL of an herbicide containing sodium chlorate. The total amount of sodium chlorate ingested was 27 grams. The patient gradually recovered following daily intermittent hemodialysis sessions and supportive care (Ranghino et al, 2006).
TOXICITY AND RISK ASSESSMENT VALUES
POTASSIUM CHLORATE SODIUM CHLORATE LD50- (ORAL)MOUSE: LD50- (ORAL)RABBIT: LD50- (SKIN)RABBIT: LD50- (ORAL)RAT:
-STANDARDS AND LABELS
SHIPPING REGULATIONS
- DOT -- Table of Hazardous Materials and Special Provisions for UN/NA Number 3210 (49 CFR 172.101, 2005):
Hazardous materials descriptions and proper shipping name: Chlorates, inorganic, aqueous solution, n.o.s Symbol(s): Not Listed Hazard class or Division: 5.1 Identification Number: UN3210 Packing Group: II Label(s) required (if not excepted): 5.1 Special Provisions: IB2, T4, TP1 IB2: Authorized IBCs: Metal (31A, 31B and 31N); Rigid plastics (31H1 and 31H2); Composite (31HZ1). Additional Requirement: Only liquids with a vapor pressure less than or equal to 110 kPa at 50 °C (1.1 bar at 122 °F), or 130kPa at 55 °C (1.3 bar at 131 °F) are authorized. T4: Minimum test pressure (bar): 2.65; Minimum shell thickness (in mm-reference steel) (See sxn.178.274(d)): sxn.178.274(d)(2); Pressure-relief requirements (See sxn.178.275(g)): Normal; Bottom opening requirements (See sxn.178.275(d)): sxn.178.275(d)(3). TP1: The maximum degree of filling must not exceed the degree of filling determined by the following: [Degree of filling = 97/1+alpha(tr - tf)], where tr is the maximum mean bulk temperature during transport, and tf is the temperature in degrees celsius of the liquid during filling.
Packaging Authorizations (refer to 49 CFR 173.***): Exceptions: 152 Non-bulk packaging: 202 Bulk packaging: 242
Quantity Limitations: Vessel Stowage Requirements: Vessel stowage location: B B: (i) The material may be stowed "on deck" or "under deck" on a cargo vessel and on a passenger vessel carrying a number of passengers limited to not more than the larger of 25 passengers, or one passenger per each 3 m of overall vessel length; and (ii) "On deck only" on passenger vessels in which the number of passengers specified in paragraph (k)(2)(i) of this section is exceeded.
Vessel stowage other: 56, 58, B101
Hazardous materials descriptions and proper shipping name: Chlorates, inorganic, aqueous solution, n.o.s. Symbol(s): Not Listed Hazard class or Division: 5.1 Identification Number: UN3210 Packing Group: III Label(s) required (if not excepted): 5.1 Special Provisions: IB2, T4, TP1 IB2: Authorized IBCs: Metal (31A, 31B and 31N); Rigid plastics (31H1 and 31H2); Composite (31HZ1). Additional Requirement: Only liquids with a vapor pressure less than or equal to 110 kPa at 50 °C (1.1 bar at 122 °F), or 130kPa at 55 °C (1.3 bar at 131 °F) are authorized. T4: Minimum test pressure (bar): 2.65; Minimum shell thickness (in mm-reference steel) (See sxn.178.274(d)): sxn.178.274(d)(2); Pressure-relief requirements (See sxn.178.275(g)): Normal; Bottom opening requirements (See sxn.178.275(d)): sxn.178.275(d)(3). TP1: The maximum degree of filling must not exceed the degree of filling determined by the following: [Degree of filling = 97/1+alpha(tr - tf)], where tr is the maximum mean bulk temperature during transport, and tf is the temperature in degrees celsius of the liquid during filling.
Packaging Authorizations (refer to 49 CFR 173.***): Exceptions: 152 Non-bulk packaging: 202 Bulk packaging: 241
Quantity Limitations: Vessel Stowage Requirements: Vessel stowage location: B B: (i) The material may be stowed "on deck" or "under deck" on a cargo vessel and on a passenger vessel carrying a number of passengers limited to not more than the larger of 25 passengers, or one passenger per each 3 m of overall vessel length; and (ii) "On deck only" on passenger vessels in which the number of passengers specified in paragraph (k)(2)(i) of this section is exceeded.
Vessel stowage other: 56, 58, B101
- DOT -- Table of Hazardous Materials and Special Provisions for UN/NA Number 1461 (49 CFR 172.101, 2005):
- ICAO International Shipping Name for UN3210 (ICAO, 2002):
- ICAO International Shipping Name for UN1461 (ICAO, 2002):
-HANDLING AND STORAGE
STORAGE
Chlorate explosives must not be stored together with ammonium nitrate explosives, since ammonium chlorate, which is formed when these two substances are brought in contact, decomposes and explodes (Meyer, 1987).
-PERSONAL PROTECTION
SUMMARY
- RECOMMENDED PROTECTIVE CLOTHING - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004)
Wear positive pressure self-contained breathing apparatus (SCBA). Wear chemical protective clothing that is specifically recommended by the manufacturer. It may provide little or no thermal protection. Structural firefighters' protective clothing will only provide limited protection.
RESPIRATORY PROTECTION
- Refer to "Recommendations for respirator selection" in the NIOSH Pocket Guide to Chemical Hazards on TOMES Plus(R) for respirator information.
-PHYSICAL HAZARDS
FIRE HAZARD
POTENTIAL FIRE OR EXPLOSION HAZARDS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) These substances will accelerate burning when involved in a fire. Some may decompose explosively when heated or involved in a fire. May explode from heat or contamination. Some will react explosively with hydrocarbons (fuels). May ignite combustibles (wood, paper, oil, clothing, etc.). Containers may explode when heated. Runoff may create fire or explosion hazard.
Chlorates are dangerous fire hazards when in contact with flammable matter. When contaminated with oxidizable materials, they are particularly sensitive to friction, heat, and shock (Sax & Lewis, 1989).
- FIRE CONTROL/EXTINGUISHING AGENTS
SMALL FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) LARGE FIRE PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) Flood fire area with water from a distance. Move containers from fire area if you can do it without risk. Do not move cargo or vehicle if cargo has been exposed to heat. Fight fire from maximum distance or use unmanned hose holders or monitor nozzles. Cool containers with flooding quantities of water until well after fire is out. ALWAYS stay away from tanks engulfed in fire. For massive fire, use unmanned hose holders or monitor nozzles; if this is impossible, withdraw from area and let fire burn.
EXPLOSION HAZARD
- When heated to decomposition, chlorates emit toxic fumes of chlorides and explode (Sax & Lewis, 1989).
- Chlorates present a dangerous explosion hazard when shocked, exposed to heat, or rubbed, particularly when contaminated with (Sax & Lewis, 1989):
- When mixed with combustible materials, chlorates may form explosive mixtures. For instance, potassium chlorate, when mixed with sulfur or with other combustible substances, explodes on friction (Sax & Lewis, 1989).
- Pure chlorates which have been spilled on the floor, or mixed with small amounts of impurities, become very sensitive to shock and friction (Sax & Lewis, 1989).
DUST/VAPOR HAZARD
- When heated to decomposition, chlorates emit toxic fumes of chlorides and explode (Sax & Lewis, 1989).
REACTIVITY HAZARD
- When heated to decomposition, chlorates emit toxic fumes of chlorides and explode (Sax & Lewis, 1989).
- When contaminated with oxidizable materials, chlorates are particularly sensitive to friction, heat, and shock (Sax & Lewis, 1989).
- Chlorates are powerful oxidizing agents and can undergo violent reactions with reducing materials (Sax & Lewis, 1989).
EVACUATION PROCEDURES
Editor's Note: This material is not listed in the Table of Initial Isolation and Protective Action Distances. LARGE SPILL - PUBLIC SAFETY EVACUATION DISTANCES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) FIRE - PUBLIC SAFETY EVACUATION DISTANCES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions.
PUBLIC SAFETY MEASURES - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) CALL Emergency Response Telephone Number on Shipping Paper first. If Shipping Paper not available or no answer, refer to appropriate telephone number: MEXICO: SETIQ: 01-800-00-214-00 in the Mexican Republic; For calls originating in Mexico City and the Metropolitan Area: 5559-1588; For calls originating elsewhere, call: 011-52-555-559-1588.
CENACOM: 01-800-00-413-00 in the Mexican Republic; For calls originating in Mexico City and the Metropolitan Area: 5550-1496, 5550-1552, 5550-1485, or 5550-4885; For calls originating elsewhere, call: 011-52-555-550-1496, or 011-52-555-550-1552; 011-52-555-550-1485, or 011-52-555-550-4885.
ARGENTINA: CIQUIME: 0-800-222-2933 in the Republic of Argentina; For calls originating elsewhere, call: +54-11-4613-1100.
BRAZIL: PRÓ-QUÍMICA: 0-800-118270 (Toll-free in Brazil); For calls originating elsewhere, call: +55-11-232-1144 (Collect calls are accepted).
COLUMBIA: CISPROQUIM: 01-800-091-6012 in Colombia; For calls originating in Bogotá, Colombia, call: 288-6012; For calls originating elsewhere, call: 011-57-1-288-6012.
CANADA: UNITED STATES:
For additional details see the section entitled "WHO TO CALL FOR ASSISTANCE" under the ERG Instructions. As an immediate precautionary measure, isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids. Keep unauthorized personnel away. Stay upwind. Keep out of low areas. Ventilate closed spaces before entering.
CONTAINMENT/WASTE TREATMENT OPTIONS
SPILL OR LEAK PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) Keep combustibles (wood, paper, oil, etc.) away from spilled material. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Stop leak if you can do it without risk. Do not get water inside containers.
RECOMMENDED PROTECTIVE CLOTHING - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) Wear positive pressure self-contained breathing apparatus (SCBA). Wear chemical protective clothing that is specifically recommended by the manufacturer. It may provide little or no thermal protection. Structural firefighters' protective clothing will only provide limited protection.
No information on disposal guidelines for chlorates was found in available references at the time of this review. BIODEGRATION: Anaerobic microbial removal of chlorate was the subject of this laboratory study. Four bacterial strains that reduced chlorate were isolated and tested in the study. The best isolate was used in a pilot plant at a Swedish Kraft mill and demonstrated practical operating conditions (Malmqvist & Welander, 1992).
SMALL LIQUID SPILL PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004) SMALL DRY SPILL PRECAUTIONS - EMERGENCY RESPONSE GUIDEBOOK, GUIDE 140 (ERG, 2004)
-ENVIRONMENTAL HAZARD MANAGEMENT
POLLUTION HAZARD
- No information on the pollution hazard of chlorates was found in available references at the time of this review.
ENVIRONMENTAL FATE AND KINETICS
ENVIRONMENTAL TOXICITY
- No information on the environmental toxicity of chlorates was found in available references at the time of this review.
-PHYSICAL/CHEMICAL PROPERTIES
MOLECULAR WEIGHT
- POTASSIUM CHLORATE: 122.55 (Budavari, 1996)
- SODIUM CHLORATE: 106.44 (Budavari, 1996)
DESCRIPTION/PHYSICAL STATE
- POTASSIUM CHLORATE: odorless; cooling saline taste
- Chlorates are generally white in color (AAR, 1987).
- Chlorates can be a crystalline solid, slurry or sludge of crystalline material (AAR, 1987).
DENSITY
- OTHER TEMPERATURE AND/OR PRESSURE
SOLUBILITY
POTASSIUM CHLORATE: 7 g/100 mL (at 20 degrees C) SODIUM CHLORATE Chlorates, n.o.s. and chlorates, n.o.s., wet are soluble in water (AAR, 1987).
-REFERENCES
GENERAL BIBLIOGRAPHY- 49 CFR 172.101: Department of Transportation - Table of Hazardous Materials. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 11, 2005.
- AAR: AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 1987, pp 9-A,10-A-496.
- Alaspaa AO, Kuisma MJ, Hoppu K, et al: Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-12.
- Bernstein R: Kaliumklorat Vergiftung. Arch Exp Path Pharmacol 1930; 1:15.
- Bloxham CA, Wright N, & Hoult JG: Self-poisoning by sodium chlorate - some unusual features. Clin Tox 1979; 15:185-188.
- Budavari S: The Merck Index, 12th edition, Merck & Co, Inc, Rahway, NJ, 1996.
- Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
- Caravati EM, Knight HH, & Linscott MS: Esophageal laceration and charcoal mediastinum complicating gastric lavage. J Emerg Med 2001; 20:273-276.
- Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87.
- Cochrane WJ & Smith RP: A fatal case of accidental poisoning by chlorate of potassium: with a review of the literature. Can Med Assoc J 1940; 42:23-26.
- Cunningham NE: Chlorate poisoning - two cases diagnosed at autopsy. Med Sci Law 1982; 22:281-282.
- Dagnone D, Matsui D, & Rieder MJ: Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care 2002; 18:19-21.
- Davies P & Lond MB: Potassium-chlorate poisoning with oliguria treated by the bull regime. Lancet 1956; 612-613.
- Dunipace AJ, Beaven R, Noblitt T, et al: Mutagenic potential of toluidine blue evaluated in the Ames test. Mutat Res 1992; 279(4):255-259.
- ERG: Emergency Response Guidebook. A Guidebook for First Responders During the Initial Phase of a Dangerous Goods/Hazardous Materials Incident, U.S. Department of Transportation, Research and Special Programs Administration, Washington, DC, 2004.
- Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674.
- Eysseric H, Vincent F, & Peoc'h M: A fatal case of chlorate poisoning: confirmation by ion chromatography of body fluids. J Foren Sci 2000; 45:474-477.
- FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262.
- Gettler AE & St George AV: Toxicology in children. Am J Clin Pathol 1935; 5:466.
- Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318.
- Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
- Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
- Guenther Skokan E, Junkins EP, & Corneli HM: Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med 2001; 155:683-686.
- Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473.
- Helliwell M & Nunn J: Mortality in sodium chlorate poisoning. Br Med J 1979; 1:1119.
- Herman MI, Chyka PA, & Butlse AY: Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med 1999; 33:111-113.
- Hix WR & Wilson WR: Toluidine blue staining of the esophagus: a useful adjunct in the panendoscopic evaluation of patients with squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1987; 113(8):864-865.
- Hjelt K, Lund JT, Scherling B, et al: Methaemoglobinaemia among neonates in a neonatal intensive care unit. Acta Paediatr 1995; 84(4):365-370.
- Howland MA: Antidotes in Depth. In: Goldfrank LR, Flomenbaum N, Hoffman RS, et al, eds. Goldfrank's Toxicologic Emergencies. 8th ed., 8th ed. McGraw-Hill, New York, NY, 2006, pp 826-828.
- ICAO: Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2003-2004. International Civil Aviation Organization, Montreal, Quebec, Canada, 2002.
- Jackson RC, Elder WJ, & McDonnell H: Sodium chlorate poisoning complicated by acute renal failure. Lancet 1961; 2:1381-1383.
- Jansen H & Zeldenrust J: Homicidal chronic sodium chlorate poisoning. Forens Sci 1972; 1:103-105.
- Kiese M , Lorcher W , Weger N , et al: Comparative studies on the effects of toluidine blue and methylene blue on the reduction of ferrihaemoglobin in man and dog. Eur J Clin Pharmacol 1972; 4(2):115-118.
- Klendshoj NC, Burke WJ, & Anthone R: Chlorate poisoning. JAMA 1962; 180:1133-1134.
- Knight RK, Trounce JR, & Cameron JS: Suicidal chlorate poisoning treated with peritoneal dialysis. Br Med J 1967; 3:601-602.
- Lee DBN, Brown DL, & Baker LRI: Haematological complications of chlorate poisoning. Br Med J 1970; 2:31-32.
- Lewis RJ Sr: Sax's Dangerous Properties of Industrial Materials, 9th ed, Van Nostrand Reinhold, New York, NY, 1996.
- Lindenmann J, Matzi V, Kaufmann P, et al: Hyperbaric oxygenation in the treatment of life-threatening isobutyl nitrite-induced methemoglobinemia--a case report. Inhal Toxicol 2006; 18(13):1047-1049.
- Malmqvist A & Welander T: Anaerobic removal of chlorate from bleach effluents. Water Sci Technol 1992; 25:237-242.
- Marquez A & Todd M: Acute hemolytic anemia and agranulocytosis following intravenous administration of toluidine blue. Am Pract 1959; 10:1548-1550.
- Meyer R: Explosives, 3rd ed, VCH Verlagsgesellschaft, Weinheim, Germany, 1987, pp 57-58.
- Mutlu H, Silit E, Pekkafali Z, et al: Cranial MR imaging findings of potassium chlorate intoxication. Am J Neuroradiol 2003; 24:1396-1398.
- Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
- National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
- Nemec K: Antidotes in acute poisoning. Eur J Hosp Pharm Sci Pract 2011; 17(4):53-55.
- None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253.
- O'Grady J & Jarecsni E: Sodium chlorate poisoning. Br J Clin Pract 1971; 25:38-39.
- Oliver JS, Smith H, & Watson AA: Sodium chlorate poisoning. J Forensic Sci Soc 1972; 12:445-448.
- Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
- Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529.
- Product Information: PROVAYBLUE(TM) intravenous injection, methylene blue intravenous injection. American Regent (per FDA), Shirley, NY, 2016.
- Product Information: methylene blue 1% IV injection, methylene blue 1% IV injection. American Regent, Inc (per manufacturer), Shirley, NY, 2011.
- Product Information: methylene blue 1% intravenous injection, methylene blue 1% intravenous injection. Akorn, Inc. (per manufacturer), Lake Forest, IL, 2011.
- Ranghino A, Costantini L, Deprado A, et al: A case of acute sodium chlorate self-poisoning successfully treated without conventional therapy. Nephrol Dial Transplant 2006; 21(10):2971-2974.
- Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919.
- Sax NI & Lewis RJ: Dangerous Properties of Industrial Materials, 7th ed, Van Nostrand Reinhold Company, New York, NY, 1989, pp 760.
- Sheahan BJ, Pugh DM, & Winstanley EW: Experimental sodium chlorate poisoning in dogs. Res Vet Sci 1971; 12:387-389.
- Shepherd G & Keyes DC: Methylene blue. In: Dart,RC, ed. Medical Toxicology, 3rd ed. 3rd ed, Philadelphia, PA, 2004, pp -.
- Singelmann E & Steffen C: Increased erythrocyte rigidity in chlorate poisoning (letter). J Clin Pathol 1983; 36:719.
- Smith EA & Oehme FW: A review of selected herbicides and their toxicities. Vet Hum Toxicol 1991; 33:596-608.
- Spence AM, Kiem HP, Partap S, et al: Complications of a temozolomide overdose: a case report. J Neurooncol 2006; 80(1):57-61.
- Spiller HA & Rogers GC: Evaluation of administration of activated charcoal in the home. Pediatrics 2002; 108:E100.
- Stanford SC , Stanford BJ , & Gillman PK : Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol 2010; 24(10):1433-1438.
- Stavrou A, Butcher R, & Sakula A: Accidental self-poisoning by sodium chlorate weed-killer. Practitioner 1978; 221:397-399.
- Steffen C & Seitz R: Severe chlorate poisoning: report of a case. Arch Toxicol 1981; 48:281-288.
- Steffen C & Wetzel E: Chlorate poisoning: mechanism of toxicity. Toxicology 1993; 84:217-231.
- Steffen C & Wetzel E: Pathophysiologic aspects of chlorate poisoning (Abstract). Hum Toxicol 1985; 4:541-542.
- Teunis BS, Leftwich EI, & Pierce LE: Acute methemoglobinemia and hemolytic anemia due to toluidine blue. Arch Surg 1970; 101:527-531.
- Thakore S & Murphy N: The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63-65.
- Timperman J & Maes R: Suicidal poisoning by sodium chlorate: a report of three cases. J Forens Med 1966; 13:123-129.
- U.S. Food and Drug Administration: FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. U.S. Food and Drug Administration. Silver Spring, MD. 2011. Available from URL: http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. As accessed 2011-07-26.
- Vakili M: Chlorate poisoning in childhood - a case report. Environ Child Health 1977; 119.
- Vale JA, Kulig K, American Academy of Clinical Toxicology, et al: Position paper: Gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943.
- Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719.
- Winek CL, Collom WD, & Martineau P: Toluidine blue intoxication. Clin Toxicol 1969; 2:1-3.
- do Nascimento TS, Pereira RO, de Mello HL, et al: Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol 2008; 58(6):651-664.
|